Shape combines Cagrilintide and Semaglutide in a single precision-dosed vial — mirroring the CagriSema combination studied in Phase 3 clinical trials for its dual-mechanism approach to metabolic and appetite regulation research. Each box contains 10 vials of lyophilized powder.
Third-party COA available on request. For research purposes only.


Reviews
There are no reviews yet.